Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by Accountprinceon May 27, 2022 11:18am
196 Views
Post# 34712185

RE:Spectral Medical content from Baxter Invester Day 2022

RE:Spectral Medical content from Baxter Invester Day 2022Thanks Tom - the presentation certainly highlights the PMX and EAA products.  I don't think Baxter would put them in as definitively as they show here if they weren't virtually certain of success.  Heather as well would want to maintain her credibility so would be reluctant to commit to anything that could come back to haunt her.  This is HUGE as it does validate some of the things Spectral management has been saying.  But Baxter has the credibility Spectral management lacks right now.  Anyone that is still skeptical of success should spend some time to evaluate their position.

MM - thanks for your musings - always appreciated.  My only comment is that Baxter is not a "tire kicker" but truly a partner based on the Investor presentation they did independantly.  It would be wonderful to be an insider and know the deal with Baxter unredacted.  At least now we know Spectral is cleared in Baxter's plans.  Very encouraging.
<< Previous
Bullboard Posts
Next >>